These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1079 related items for PubMed ID: 9752815

  • 1. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 Sep 19; 352(9132):930-42. PubMed ID: 9752815
    [Abstract] [Full Text] [Related]

  • 2. Multi-agent chemotherapy for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group.
    Cochrane Database Syst Rev; 2002 Sep 19; (1):CD000487. PubMed ID: 11869577
    [Abstract] [Full Text] [Related]

  • 3. WITHDRAWN: Multi-agent chemotherapy for early breast cancer.
    Clarke MJ.
    Cochrane Database Syst Rev; 2008 Oct 08; 2008(4):CD000487. PubMed ID: 18843612
    [Abstract] [Full Text] [Related]

  • 4. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May 16; 351(9114):1451-67. PubMed ID: 9605801
    [Abstract] [Full Text] [Related]

  • 5. Tamoxifen for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group.
    Cochrane Database Syst Rev; 2001 May 16; (1):CD000486. PubMed ID: 11279694
    [Abstract] [Full Text] [Related]

  • 6. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
    Lancet; 2001 May 16; 365(9472):1687-717. PubMed ID: 15894097
    [Abstract] [Full Text] [Related]

  • 7. WITHDRAWN: Tamoxifen for early breast cancer.
    Clarke MJ.
    Cochrane Database Syst Rev; 2008 Oct 08; 2008(4):CD000486. PubMed ID: 18843611
    [Abstract] [Full Text] [Related]

  • 8. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1992 Jan 04; 339(8784):1-15. PubMed ID: 1345950
    [Abstract] [Full Text] [Related]

  • 9. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, Cutter D, Darby S, McGale P, Taylor C, Wang YC, Bergh J, Di Leo A, Albain K, Swain S, Piccart M, Pritchard K.
    Lancet; 2012 Feb 04; 379(9814):432-44. PubMed ID: 22152853
    [Abstract] [Full Text] [Related]

  • 10. Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1996 Nov 02; 348(9036):1189-96. PubMed ID: 8898035
    [Abstract] [Full Text] [Related]

  • 11. A systematic overview of chemotherapy effects in breast cancer.
    Bergh J, Jönsson PE, Glimelius B, Nygren P, SBU-group. Swedish Council of Technology Assessment in Health Care.
    Acta Oncol; 2001 Nov 02; 40(2-3):253-81. PubMed ID: 11441936
    [Abstract] [Full Text] [Related]

  • 12. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
    Fisher B, Jeong JH, Anderson S, Wolmark N.
    J Natl Cancer Inst; 2004 Dec 15; 96(24):1823-31. PubMed ID: 15601638
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Clarke M, Coates AS, Darby SC, Davies C, Gelber RD, Godwin J, Goldhirsch A, Gray R, Peto R, Pritchard KI, Wood WC.
    Lancet; 2008 Jan 05; 371(9606):29-40. PubMed ID: 18177773
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B.
    Dan Med J; 2016 May 05; 63(5):. PubMed ID: 27127018
    [Abstract] [Full Text] [Related]

  • 15. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 2000 May 20; 355(9217):1757-70. PubMed ID: 10832826
    [Abstract] [Full Text] [Related]

  • 16. The effect of adjuvant tamoxifen: the latest results from the Cancer Research Campaign Adjuvant Breast Trial. Cancer Research Campaign Breast Cancer Trials Group.
    Eur J Cancer; 1992 May 20; 28A(4-5):904-7. PubMed ID: 1524921
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis.
    Cole BF, Gelber RD, Gelber S, Coates AS, Goldhirsch A.
    Lancet; 2001 Jul 28; 358(9278):277-86. PubMed ID: 11498214
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.